Injection vials producer Gerresheimer is expanding its capacities for glass vials at the Wertheim, Germany site and at two further sites in China and the U.S.. The company is investing in production in Wertheim to increase vials capacity by 150 million vials per year and plans to create 70 new jobs for this purpose. The Federal Ministry of Economy and Climate Action supports the investment within the framework of federal funding of production equipment of borosilicate tubular glass and glass vials for use in vaccine production.

Gerresheimer is one of the world’s largest manufacturers of the products required for vaccination campaigns, among other things. Until now, the company has primarily served the European demand for vials from its plants in Boleslawiec (Poland) and Chalon (France). The investment will make the Wertheim plant one of the leading vial production sites in Europe.

“We already produce almost a third of the world’s glass vials worldwide,” said Dietmar Siemssen, CEO, Gerresheimer AG. “With the expansion of our global capacities we are consistently implementing our growth strategy. By the end of 2022, we will be the world’s leading producer of glass vials and manufacture the highest-quality and most innovative products.”

The German Federal Ministry for Economic Affairs and Climate Action is supporting the investment in Wertheim. By expanding its production capacity in Wertheim, Gerresheimer is making a contribution to improving the supply of glass vials to European vaccine manufacturers, among other things. In the long term, Gerresheimer’s management expects an increasing demand for drugs which have to be injected—and therefore a higher demand for vials. The global pandemic has highlighted the importance of a reliable and high-quality supply of injection solutions.